Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could hip and knee replacement patients go home the same day?

NCT ID NCT07834034

Knowledge-focused Sponsor: Helse Møre og Romsdal HF Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 22, 2026 · Last updated Sep 23, 2026 · Updated 1 time

Summary

Researchers in Møre og Romsdal, Norway, are studying whether patients having hip or knee replacement can safely go home the same day instead of staying overnight. The study follows 300 adults aged 18 to 80 who are scheduled for these operations at three hospitals. Patients are checked against set criteria for same-day discharge, and researchers track recovery, pain, complications, emergency visits, readmissions, and quality of life for up to three months.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
same-day discharge pathways for hip and knee replacement surgery
What this could lead to
If the approach proves safe and workable, more patients could go home the same day they have hip or knee replacement surgery, avoiding an overnight hospital stay.
What could go wrong
This is an observational study, not a randomized experiment, so it can show patterns but not prove cause and effect. Same-day discharge may not suit everyone, and complications or readmissions could still occur after patients leave.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 300 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Oct 2026

An estimate. Start dates often move.

Expected to finish

Jul 2036

An estimate. End dates often move.

Lead sponsor

A government agency

The lead sponsor is a government body.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

The study population will consist of consecutive adult patients (18 - 80 years old) scheduled for primary total hip arthroplasty, total knee arthroplasty, or unicompartmental knee arthroplasty at the participating hospitals in Møre og Romsdal, Norway. All patients undergoing an eligible procedure during the recruitment period will be prospectively screened for suitability for the standardized day-case pathway. Patients who meet the predefined clinical, functional, cognitive, and logistical eligibility criteria and provide informed consent will be included in the prospective cohort.

Ages

18 to 80 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients 18-80 years old scheduled for primary TKA, UKA or THA Exclusion Criteria: * Patient not motivated for daycase surgery, lack of adult caregiver staying with the patient for the first 24 hours post-discharge, ASA class 3 (if not approved by anesthesiologist) and 4, travel distance to acute hospital no more than 1 hour (ferry-free), dementia or other reasons for lacking compliance (e.g. substance abuse, severe psychiatric disorder etc.) BMI \>40 kg/m2, patients with anticipated high level of pain due to previous experience, comorbidity (i.e. chronic pain syndrome, fibromyalgia), patients treated with opoid analgesics on a regular basis prior to surgery.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Hip osteoarthritis are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

osteoarthritis osteoarthritis, hip osteoarthritis, knee osteonecrosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Hip osteoarthritis Knee osteoarthritis Osteoarthritis Osteonecrosis

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    3 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Nordmøre and Romsdal Hospital (SNR) Hjelset

    Hjelset, Møre and Romsdal, 6450, Norway

  • Volda Hospital

    Volda, Møre and Romsdal, Norway

  • Ålesund Sjukehus

    Ålesund, Møre and Romsdal, Norway

More trials for these conditions

Other studies related to the condition(s) this trial covers.